title: Impact of CD34-positive cell dose on outcome after peripheral blood stem cell allogeneic transplantation prepared with ATG-based reduced intensity conditioning regimen.
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.|Medical School, Aix-Marseille University, Marseille, France.|Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Marseille, F-13009, France.
authors.forename: Aude
authors.initials: A
authors.lastname: Collignon
authors.affiliation: Cell Therapy Facility, Institut Paoli-Calmettes, Marseille, France.|CIC Biothérapies: Inserm CBT-1409, Marseille, France.
authors.forename: Boris
authors.initials: B
authors.lastname: Calmels
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: Samia
authors.initials: S
authors.lastname: Harbi
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: Sabine
authors.initials: S
authors.lastname: Fürst
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: Angela
authors.initials: A
authors.lastname: Granata
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Faucher
authors.affiliation: Cell Therapy Facility, Institut Paoli-Calmettes, Marseille, France.|CIC Biothérapies: Inserm CBT-1409, Marseille, France.
authors.forename: Claude
authors.initials: C
authors.lastname: Lemarie
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.|Medical School, Aix-Marseille University, Marseille, France.|Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Marseille, F-13009, France.
authors.forename: Pierre-Jean
authors.initials: PJ
authors.lastname: Weiller
authors.affiliation: Cell Therapy Facility, Institut Paoli-Calmettes, Marseille, France.|CIC Biothérapies: Inserm CBT-1409, Marseille, France.
authors.forename: Christian
authors.initials: C
authors.lastname: Chabannon
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.|Medical School, Aix-Marseille University, Marseille, France.|Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Marseille, F-13009, France.
authors.forename: Didier
authors.initials: D
authors.lastname: Blaise
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.|Medical School, Aix-Marseille University, Marseille, France.|Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Marseille, F-13009, France.
authors.forename: Raynier
authors.identifier: http://orcid.org/0000-0002-4045-8310
authors.initials: R
authors.lastname: Devillier
mesh_terms: D000328:Adult; D000368:Aged; D064591:Allografts; D018952:Antigens, CD34; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation; D000072916:Peripheral Blood Stem Cells; D012189:Retrospective Studies; D019172:Transplantation Conditioning
chemical_list: D018952:Antigens, CD34; D000961:Antilymphocyte Serum